MDL Panel Grants Transfer Of Aflibercept BPCIA Case - Patent

As we previously reported, on January 11, 2024, Regeneron Pharmaceuticals, Inc. ("Regeneron") moved to establish a multi-district litigation ("MDL") for its aflibercept BPCIA litigation...

Related Keywords

West Virginia ,United States ,Northern District ,Virginia ,California ,Mylan Biocon ,Samsung Bioepis ,Thomass Kleeh ,Samsung ,Regeneron Pharmaceuticals Inc ,Amgen ,Amgen Inc ,Judicial Panel On Multidistrict ,Regeneron Pharmaceuticals ,Chief Judge Thomas ,Judicial Panel ,Judge Kleeh ,Big Molecule Watch ,